Skip to main content
FinSpry Logo
FinSpry
RCUS logo
RCUS
(NYSE)
Arcus Biosciences, Inc.
$30.34-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Arcus Biosciences (RCUS) Stock Price & Financial Analysis

Arcus Biosciences Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$29.74 - $30.56
52-Week High$31.74
52-Week Low$9.81
Open$29.89
Volume1.06M
Average Volume (3M)1.15M
Market Cap3.80B
Shares Outstanding125.40M
Price to Sales (P/S)15.71
Price to Book (P/B)7.07
EV/EBITDA-10.97
Revenue (TTM)236.00M
Net Income (TTM)-369.00M
Free Cash Flow (TTM)-489.00M
EPS (TTM)$-3.31
Profit Margin-156.36%
Operating Margin-168.64%
Return on Equity (ROE)-70.42%
Debt to Equity0.22
50-Day MA$27.78
200-Day MA$23.90
52-Week Change184.50%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Arcus Biosciences

What is the current stock price for RCUS?

As of the latest trading session, RCUS stock trades at $30.34. The 52-week range is $9.81–$31.74, with a day range of $29.74–$30.56.

What is the P/E ratio for RCUS?

The P/E ratio (Price-to-Earnings) for RCUS is shown in the Key Statistics section. This valuation metric helps compare Arcus Biosciences, Inc. to industry peers.

Does RCUS pay dividends?

Arcus Biosciences does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for RCUS?

Based on 4 analysts, the consensus for RCUS is Buy.

What is the market cap of RCUS?

Arcus Biosciences's market capitalization is $3.80B, classifying it as a mid-cap company. Arcus Biosciences operates in the Healthcare sector within the Biotechnology industry.